Your browser does not support the NLM PubReader view.

Go to this page to see a list of supporting browsers.

Analysis of research trends on microneedle patches loaded pharmacopuncture preparation: A Literature Review

Article information

J Korean Med. 2024;45(2):159-168
Publication date (electronic) : 2024 June 01
doi : https://doi.org/10.13048/jkm.24032
Minjeong Kimorcid_icon
Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Sangji University
Correspondence to: Minjeong Kim, Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Sangji University, 83 Sangjidae-ro, Wonju, Gangwon-do, 26338, Republic of Korea, Tel: +82-33-741-9289, Fax: +82-33-741-9141, E-mail: goodykmj@hanmail.net
Received 2024 April 23; Revised 2024 May 9; Accepted 2024 May 9.

Abstract

Objectives

The purpose of this study is to review the dissolving microneedle patches literature, which is loaded with pharmacopuncture preparation. By exploring types of pharmacopuncture preparation applied to microneedle patches, we aim to develop new potential preparation.

Methods

This review included both animal and human studies that published between February 2015 and March 2024. After searching, no RCTs were found, the final selected in-vivo and in-vitro studies were analyzed. A total of 13 articles were retrieved from the international database, and a total of 5 articles were retrieved from the domestic database. Finally, 7 studies were selected, and evaluated by the published year, country of publication, types of animal model, disease type, retention type, evaluation index, adverse effects.

Conclusions

According to 7 studies, pharmacopuncture preparation coated dissolving microneedle patch include bee venom, placenta, and ginseng in osteoarthritis, rheumatoid arthritis, hypertrophic scar, psoriasis, and neurodegeneration. In the future, follow-up studies on the safety, retention time, and optimal effective dose of the microneedle patches are expected.

Keywords: microneedle patch; dissolving microneedle patch; pharmacopuncture preparation; herbal agents loaded
Fig. 1

Flowchart of the study selection process according to PRISMA. PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses.

Characteristics of the included in-vivo studies (6 articles)

Characteristics of the included in-vitro studies. (1 article)

ACKNOWLEDGMENTS

I thank graduate student Chang-Woo Sun for helping data extraction and organization.

Notes

INTEREST

The author has no conflicts of interest to declare.

ETHICAL STATEMENT

This research did not involve any human or animal experiment.

FUNDING

None.

References

1. Moore LE, Vucen S, Moore AC. Trends in drug- and vaccine-based dissolvable microneedle materials and methods of fabrication. European Journal of Pharmaceutics and Biopharmaceutics 2022;173:54–72. https://www.sciencedirect.com/science/article/pii/S0939641122000340. 10.1016/j.ejpb.2022.02.013.
2. Wan W, Li Y, Wang J, et al. PLGA nanoparticle-based dissolving microneedle vaccine of clostridium perfringens ε toxin. Toxins 2023;15(7):461.
3. Moon S, Richter-Roche M, Resch TK, et al. Microneedle patch as a new platform to effectively deliver inactivated polio vaccine and inactivated rotavirus vaccine. NPJ vaccines 2022;7:26.
4. Lee I, Lin W, Shu J, Tsai S, Chen C, Tsai M. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice. Journal of biomedical materials research Part A 2017;105(1):84–93.
5. Demir B, Rosselle L, Voronova A, et al. Innovative transdermal delivery of insulin using gelatin methacrylate-based microneedle patches in mice and mini-pigs. Nanoscale horizons 2022;7(2):174–184.
6. Liang C, Wang R, He T, et al. Revolutionizing diabetic wound healing: The power of microneedles. Chinese Journal of Plastic and Reconstructive Surgery 2023;5(4):185–194. https://www.sciencedirect.com/science/article/pii/S2096691123000717. 10.1016/j.cjprs.2023.12.004.
7. Huang Y, Li J, Wang Y, et al. Intradermal delivery of an angiotensin II receptor blocker using a personalized microneedle patch for treatment of hypertrophic scars. Biomaterials science 2023;11(2):583–595.
8. Lee Y, Kumar S, Kim SH, et al. Odorless glutathione microneedle patches for skin whitening. Pharmaceutics 2020;12(2):100.
9. Choi H, Hong J, Seo Y, et al. Self-assembled oligopeptoplex-loaded dissolving microneedles for adipocyte-targeted anti-obesity gene therapy. Adv Mater 2024;:e2309920. 10.1002/adma.202309920.
10. Huang S, Wen T, Wang J, et al. Nanoparticle -integrated dissolving microneedles for the co-delivery of R848/aPD-1 to synergistically reverse the immunosuppressive microenvironment of triple-negative breast cancer. Acta Biomater 2024;176:344–355. 10.1016/j.actbio.2024.01.009.
11. Zhu T, Yu X, Yi X, et al. Lidocaine-loaded hyaluronic acid adhesive microneedle patch for oral mucosal topical anesthesia. Pharmaceutics 2022;14(4):686.
12. Castilla-Casadiego D, Miranda-Muñoz KA, Roberts JL, et al. Biodegradable microneedle patch for delivery of meloxicam for managing pain in cattle. PLoS ONE 2022;17(8):e0272169.
13. Zheng L, Chen Y, Gu X, et al. Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis. Journal of Controlled Release 2023;365:274. 10.1016/j.jconrel.2023.11.029.
14. Yan Q, Wang W, Weng J, et al. Dissolving microneedles for transdermal delivery of huperzine A for the treatment of alzheimer’s disease. Drug Deliv 2020;27(1):1147–1155.
15. Shi H, Zhou J, Wang Y, et al. A rapid corneal healing microneedle for efficient ocular drug delivery. Small 2022;18(4):2104657.
16. Zhang X, Hasani-Sadrabadi MM, Zarubova J, et al. Immunomodulatory microneedle patch for periodontal tissue regeneration. Matter 2022;5(2):666–682. 10.1016/j.matt.2021.11.017.
17. Zhang R, Miao Q, Deng D, Wu J, Miao Y, Li Y. Research progress of advanced microneedle drug delivery system and its application in biomedicine. Colloids and Surfaces B: Biointerfaces 2023;226:113302. https://www.sciencedirect.com/science/article/pii/S0927776523001807. 10.1016/j.colsurfb.2023.113302.
18. Chun H, Song H. Analysis of trend of studies on microneedle treatment system (MTS). J Pharmacopuncture 2021;24(4):182. 10.3831/kpi.2021.24.4.182.
19. 박선주 박지연 우성천. 국내 한방 패치 특허 현황에 대한 분석연구. society of preventive korean medicine 2018;22(1):45. 10.25153/spkom.2018.22.1.004.
20. Nguyen CD, Yoo J, An EJ, et al. Pharmacokinetic improvement provided by microneedle patch in delivering bee venom, a case study in combating scopolamine-induced neurodegeneration in mouse model. Drug Delivery 2022;29(1):2855. 10.1080/10717544.2022.2116129.
21. Jang HM, Kim H, Park S, et al. Dissolvable microneedle patch increases the therapeutic effect of jawoongo on DNCB-induced atopic dermatitis in mice. Complement Med Res 2023;30(1):1–10. 10.1159/000525451.
22. Song J, Lee G, Jung M, Choi J, Park S. RCT efficacy and safety of a biodegradable hyaluronic acid microneedle patch for dry skin in atopic dermatitis: A single-blinded, split-body, randomized controlled trial
23. Huang C, Gou K, Yue X, et al. A novel hyaluronic acid-based dissolving microneedle patch loaded with ginsenoside Rg3 liposome for effectively alleviate psoriasis. Materials & Design 2022;:224. 10.1016/j.matdes.2022.111363.
24. Du G, He P, Zhao J, et al. Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment. Journal of controlled release: official journal of the Controlled Release Society 2021;336:537–548.
25. Nguyen CD, Yoo J, An EJ, et al. Pharmacokinetic improvement provided by microneedle patch in delivering bee venom, a case study in combating scopolamine-induced neurodegeneration in mouse model. Drug Delivery 2022;29(1):2855. 10.1080/10717544.2022.2116129.
26. Cheng A, Zhang S, Wang B, Gao Y. Layered dissolving microneedle containing a three-drug combination on the treatment of hypertrophic scar. Journal of Drug Delivery Science and Technology 2024;:95. 10.1016/j.jddst.2024.105572.
27. Zheng L, Chen Y, Gu X, et al. Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis. J Control Release 2024;365:274–285. 10.1016/j.jconrel.2023.11.029.
28. Zhao M, Bai J, Lu Y, et al. Anti-arthritic effects of microneedling with bee venom gel. Journal of Traditional Chinese Medical Sciences 2016;3(4):256. 10.1016/j.jtcms.2016.09.005.
29. Tansathien K, Suriyaamporn P, Ngawhirunpat T, Opanasopit P, Rangsimawong W. A novel approach for skin regeneration by a potent bioactive placental-loaded microneedle patch: Comparative study of deer, goat, and porcine placentas. Pharmaceutics 2022;14(6)10.3390/pharmaceutics14061221.
30. Yang L, Zhao W, Gong X, et al. Exploring potential network pharmacology-and molecular docking-based mechanism of melittin in treating rheumatoid arthritis. Medicine (Baltimore) 2023;102(32):e34728. 10.1097/MD.0000000000034728.
31. Goo B, Lee J, Park C, Yune T, Park Y. Bee venom alleviated edema and pain in monosodium urate crystals-induced gouty arthritis in rat by inhibiting inflammation. Toxins (Basel) 2021;13(9):661. 10.3390/toxins13090661.
32. Park J, Jang KM, Park K. Effects of apamin on MPP(+)-induced calcium overload and neurotoxicity by targeting CaMKII/ERK/p65/STAT3 signaling pathways in dopaminergic neuronal cells. Int J Mol Sci 2022;23(23):15255. 10.3390/ijms232315255.
33. Nguyen UT, Nguyen LTH, Kim B, Choi M, Yang I, Shin H. Natural compound mixture, containing emodin, genipin, chlorogenic acid, cimigenoside, and ginsenoside Rb1, ameliorates psoriasis-like skin lesions by suppressing inflammation and proliferation in keratinocytes. Evid Based Complement Alternat Med 2020;2020:9416962. 10.1155/2020/9416962.
34. Kwon JW, Hong SE, Kang SR, Park BY. Effect of human placental extract treatment on random-pattern skin flap survival in rats. J Invest Surg 2019;32(4):304–313. 10.1080/08941939.2017.1417518.
35. Li S, Cao S, Lu H, He B, Gao B. Kirigami triboelectric spider fibroin microneedle patches for comprehensive joint management. Mater Today Bio 2024;26:101044. 10.1016/j.mtbio.2024.101044.
36. Monou PK, Andriotis E, Tzetzis D, et al. Evaluation of 3D-printed solid microneedles coated with electrosprayed polymeric nanoparticles for simultaneous delivery of rivastigmine and N-acetyl cysteine. ACS Appl Bio Mater 2024;10.1021/acsabm.3c00750.

Article information Continued

Fig. 1

Fig. 1

Flowchart of the study selection process according to PRISMA. PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses.

Table 1

Characteristics of the included in-vivo studies (6 articles)

Study Animal Model Disease Type Preparation Type Intervention Duration(day) Evaluation Index Adverse Effects
Huang C, et al. (2022) 23) Male ICR mice (6 weeks old; 20–25 g) IMQ ointment-induced psoriasis Rg3-Liposome 3 mins

  1. psoriasis area and severity index (PASI score)

  2. Histological analysis

 No comment
Du G, et al.(2021) 24) Rodent and murine AIA models

  1. Male BALB/c mice of 6–8 weeks old (body weight 18–20 g)

  2. Male Sprague Dawley (SD) rats of 6–8 weeks old (body weight 180–200 g)

 rheumatoid arthritis Melittin every other day for 8 times(total 16)

  1. body weight loss

  2. change of paw thickness

  3. clinical score of the symptoms

  4. histology of the paws

 No comment
NGUYEN CD, et al.(2022) 25) Twenty-week-old BALB/c male (38–42 g/mouse) mice scopolamine-induced neuro stress (neurodegenerative disorders) bee venom(melittin) 2

  1. Reactive oxygen species (ROS), lipid peroxidation (MDA), and adenosine triphosphate (ATP) levels

  2. Open field behavior test

 No comment
4 Morris water maze test
Cheng A, et al.(2024) 26) New Zealand white rabbits (aged 8–9 weeks) hypertrophic scar AS–ginsenoside Rb1–L–carnosine (A–G–C) once a week for six weeks thickness of the scar No comment
Zheng L, et al.(2024) 27) Male Sprague-Dawley (SD) rats rheumatoid arthritis Melittin once every 3 days for a total of 21 days

  1. Swelling of rat paw

  2. degree of joint damage(X-ray)

  3. Serum cytokine

 No comment
Zhao M, et al(2016) 28) Male Kunming mice (18e22 g) and Sprague Dawley rats sodium urate induced acute gouty arthritis Bee venom gel(BVG) 3mins level of nitric oxide in serum No comment
LPS-induced acute inflammation

Table 2

Characteristics of the included in-vitro studies. (1 article)

Study Cell Type Disease Type Preparation Type Intervention Duration(hr) Evaluation Index Adverse Effects
Tansathien, K. et al.(2022) 29)

  1. human dermal fibroblasts (NHFs)

  2. human immortalized keratinocytes (HaCaTs))

 exposed to UVB rays placental extracts (GP, DP, or PP) 24 Skin Histology Skin irritation (no pain, edema, severe redness)